scholarly article | Q13442814 |
P953 | full work available at URL | http://intl-jpet.aspetjournals.org/cgi/content/abstract/274/2/866 |
P698 | PubMed publication ID | 7636750 |
P2093 | author name string | I. Lucki | |
D. S. Kreiss | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 866-876 | |
P577 | publication date | 1995-08-01 | |
P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
P1476 | title | Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo | |
P478 | volume | 274 |
Q24643511 | 5-HT(1A) receptor function in major depressive disorder |
Q24651067 | Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions |
Q34886531 | Antidepressant-like effect of Hoodia gordonii in a forced swimming test in mice: evidence for involvement of the monoaminergic system |
Q42378356 | Beneficial effect of fluoxetine treatment aganist psychological stress is mediated by increasing BDNF expression in selected brain areas |
Q36879560 | Characterization of the potent 5-HT(1A/B) receptor antagonist and serotonin reuptake inhibitor SB-649915: preclinical evidence for hastened onset of antidepressant/anxiolytic efficacy. |
Q74126285 | Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study |
Q46767739 | Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. |
Q42077495 | Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography |
Q35822361 | DSP-1053, a novel serotonin reuptake inhibitor with 5-HT1A partial agonistic activity, displays fast antidepressant effect with minimal undesirable effects in juvenile rats |
Q37276935 | Differential regulation of serotonin-1A receptor-stimulated [35S]GTP gamma S binding in the dorsal raphe nucleus by citalopram and escitalopram |
Q35047176 | Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors |
Q44367469 | Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex |
Q38028902 | Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT. |
Q35042302 | Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo |
Q71312103 | Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors |
Q33935828 | Estradiol-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the hypothalamus is independent of estrogen receptor-beta |
Q33514619 | Fluoxetine and sertraline attenuate postischemic brain injury in mice |
Q43540497 | Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity. |
Q46431169 | Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test |
Q73692022 | In vivo electrochemical measurements of serotonin clearance in rat striatum: effects of neonatal 6-hydroxydopamine-induced serotonin hyperinnervation and serotonin uptake inhibitors |
Q36401400 | Innovative approaches for the development of antidepressant drugs: current and future strategies |
Q26827615 | Molecular and genetic basis of depression |
Q30453028 | Neurobiological changes mediating the effects of chronic fluoxetine on cocaine use. |
Q47569133 | Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders |
Q45081784 | Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats |
Q37230927 | Preclinical characterization of WAY-211612: a dual 5-HT uptake inhibitor and 5-HT (1A) receptor antagonist and potential novel antidepressant |
Q35109908 | Regulation of dorsal raphe nucleus function by serotonin autoreceptors: a behavioral perspective |
Q21129279 | Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved |
Q36547548 | Serotonergic dysfunction: brain imaging and behavioral correlates |
Q27015917 | Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder |
Q58697569 | Serotonin Reuptake Inhibitors in Obstructive Sleep Apnea: Associations in People with and without Epilepsy |
Q44085203 | Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. |
Q37000551 | Sigma receptors [σRs]: biology in normal and diseased states |
Q42521024 | The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram |
Q36825752 | The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder |
Q34265971 | The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency? |
Q92353023 | The effect of fluoxetine on astrocyte autophagy flux and injured mitochondria clearance in a mouse model of depression |
Q21132285 | The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamine and norepinephrine levels in rats |
Q35682947 | The serotonergic system and anxiety |
Q28602109 | cAMP/PKA/CREB/GLT1 signaling involved in the antidepressant-like effects of phosphodiesterase 4D inhibitor (GEBR-7b) in rats |
Search more.